Palbonamo 125 mg

Palbonamo 125 mg is a prescription medicine containing Palbociclib 125 mg. It is an oral targeted anticancer medicine mainly used in adults for certain HR-positive, HER2-negative advanced or metastatic breast cancer, usually in combination with hormonal therapy such as an aromatase inhibitor or fulvestrant, depending on the oncologist’s treatment plan. Tiny capsule, full oncology-level seriousness, because apparently biology insists on being dramatic.

Composition:

Palbociclib – 125 mg

Key Information:

Brand Name: Palbonamo
Strength: 125 mg
Active Ingredient: Palbociclib
Dosage Form: Capsules
Medicine Type: Anticancer medicine / Targeted therapy / CDK4 & CDK6 inhibitor
Manufacturer/Brand Shown: To be verified from physical label
Common Use: Treatment of HR-positive, HER2-negative advanced or metastatic breast cancer
Other Prescribed Uses: As advised by an oncologist based on cancer type, receptor status, and treatment history
Administration: Oral use
Category: Prescription medicine
Pack Size: 21 capsules, as visible on the pack

How It Works:

Palbonamo 125 mg works by blocking proteins called CDK4 and CDK6, which help control how fast cells grow and divide. By blocking these proteins, palbociclib may help slow the growth of certain breast cancer cells when used with prescribed hormonal therapy.

Potential Indications:

• HR-positive breast cancer
• HER2-negative advanced breast cancer
• Metastatic breast cancer
• Use with aromatase inhibitor as first hormonal-based therapy
• Use with fulvestrant after disease progression on hormonal therapy
• Other oncologist-directed use based on diagnosis and reports

Dosage & Storage:

Take only as directed by a qualified healthcare professional.
Follow the dosage instructions printed on the label or prescribed by the doctor.
Official product information commonly lists 125 mg once daily for 21 consecutive days followed by 7 days off treatment in a 28-day cycle, but the final dose and schedule must be decided by the treating oncologist.
Store in a cool, dry place away from direct sunlight and moisture.
Keep out of reach of children.

Important Safety Information:

Palbociclib should be used carefully under medical supervision, especially in patients with low blood counts, infection risk, liver problems, lung/breathing issues, pregnancy risk, or those taking other cancer medicines.

Possible side effects may include:

• Low white blood cell count / neutropenia
• Increased risk of infection
• Fatigue or weakness
• Nausea
• Diarrhea
• Mouth sores
• Hair thinning or hair loss
• Low red blood cells / anemia
• Low platelet count
• Abnormal liver blood tests
• Loss of appetite

Serious symptoms such as fever, chills, infection signs, unusual bleeding, severe tiredness, shortness of breath, chest discomfort, or persistent cough should be reported to a doctor immediately.

Label Verification:

Please double-check the physical product label before listing or use, including the product name, strength, active ingredient, manufacturer details, batch number, expiry date, storage instructions, dosage directions, route of administration, and packaging information.

General Information Disclaimer:

The information provided here is for general educational and product-identification purposes only. It should not be considered medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication regimen.